Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Breast cancer drug stock Olema could more than double from here, analysts say Markets November 20, 2025 Wall Road is optimistic that Olema Pharmaceutical might be growing the subsequent main breakthrough breast most cancers remedy.Earlier this month,…
